Loading...
Trademark Dashboard – UK Trademark Search & ClearanceUK Trademark — IPO
RYQLIAM
Application UK00916724924 · Registered
Quick Facts
| Application Number | UK00916724924 |
| Status | Registered |
| Owner | PHARNEXT |
| Filed | 2017-05-15 |
| Registered | 2018-12-17 |
| Renewal Due | 2027-05-15 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. RYQLIAM is currently a registered UK trademark, with renewal due on 2027-05-15. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Medicine; Pharmaceuticals; Pharmaceutical preparations; Medical preparations; Biological preparations for medical purposes; all of these products being treatments of neurodegenerative diseases.
Timeline
- Filed: 2017-05-15
- Registered: 2018-12-17
- Renewal due: 2027-05-15
About This Trademark
'RYQLIAM' is a registered trademark on the UK IPO register, owned by PHARNEXT. The application (UK00916724924) was filed on 15 May 2017 and registered on 17 December 2018. The registration is set to expire on 15 May 2027.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by CABINET LAVOIX.
Frequently Asked Questions
Who owns UK trademark UK00916724924 ('RYQLIAM')?
UK trademark UK00916724924 for the mark 'RYQLIAM' in Class 5 is recorded on the UK IPO register as owned by PHARNEXT. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00916724924 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00916724924 for the mark 'RYQLIAM' as registered.
Which goods or services does UK trademark UK00916724924 cover?
UK trademark UK00916724924 for the mark 'RYQLIAM' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Medicine; Pharmaceuticals; Pharmaceutical preparations; Medical preparations; Biological preparations for medical purposes; all of these products being treatments of neurodegenerative diseases.
When was UK trademark UK00916724924 filed?
UK trademark UK00916724924 for the mark 'RYQLIAM' was filed at the UK IPO on 15 May 2017 and registered on 17 December 2018.
When does UK trademark UK00916724924 need to be renewed?
UK trademark UK00916724924 for the mark 'RYQLIAM' is currently recorded as valid until 15 May 2027, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00916724924?
CABINET LAVOIX is listed as the attorney / representative of record for UK trademark UK00916724924 for the mark 'RYQLIAM' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.